Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Amortizatization of Intangibles (2016)

Historic Amortizatization of Intangibles for United Therapeutics (UTHR) over the last 8 years, with Q2 2016 value amounting to -$100000.0.

  • United Therapeutics' Amortizatization of Intangibles rose 7500.0% to -$100000.0 in Q2 2016 from the same period last year, while for Jun 2016 it was -$1.0 million, marking a year-over-year increase of 7167.17%. This contributed to the annual value of -$2.1 million for FY2015, which is 5924.3% up from last year.
  • Latest data reveals that United Therapeutics reported Amortizatization of Intangibles of -$100000.0 as of Q2 2016, which was up 7500.0% from -$200000.0 recorded in Q1 2016.
  • In the past 5 years, United Therapeutics' Amortizatization of Intangibles registered a high of -$100000.0 during Q2 2016, and its lowest value of -$1.6 million during Q1 2014.
  • Its 5-year average for Amortizatization of Intangibles is -$931555.6, with a median of -$1.0 million in 2013.
  • As far as peak fluctuations go, United Therapeutics' Amortizatization of Intangibles plummeted by 5944.33% in 2014, and later soared by 8000.0% in 2016.
  • Quarter analysis of 5 years shows United Therapeutics' Amortizatization of Intangibles stood at -$1.3 million in 2012, then decreased by 10.3% to -$1.4 million in 2013, then rose by 27.8% to -$1.0 million in 2014, then surged by 74.32% to -$266000.0 in 2015, then soared by 62.41% to -$100000.0 in 2016.
  • Its last three reported values are -$100000.0 in Q2 2016, -$200000.0 for Q1 2016, and -$266000.0 during Q4 2015.